Mirae Asset Global Investments
GHDX

Mirae Asset Global Investments’s Genomic Health, Inc. GHDX Stock Holding History

Mirae Asset Global Investments’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,588
Closed -$718K – 1526
2019
Q3 		$718K Buy
10,588
+6,991
+194% +$480K 0.01% 1043
2019
Q2 		$209K Buy
+3,597
New +$213K ﹤0.01% 1358

Mirae Asset Global Investments's GHDX Position: Q4 2019 in Review

Mirae Asset Global Investments sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 10,588 shares — an estimated $718K sold.

Mirae Asset Global Investments first reported a position in GHDX in Q2 2019 and held it in 2 quarters. The position peaked at $718K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Mirae Asset Global Investments reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Mirae Asset Global Investments sold 10,588 Genomic Health, Inc. shares in Q4 2019, an estimated $718K.
  • Mirae Asset Global Investments first reported a position in Genomic Health, Inc. in Q2 2019 and held it in 2 quarters.
  • Mirae Asset Global Investments's Genomic Health, Inc. position peaked at $718K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Mirae Asset Global Investments's 13F filing for Q4 2019, filed 12 Feb 2020.